Living patches engineered from human umbilical cord derived fibroblasts and endothelial progenitor cells☆

Abstract

Living tissue engineered patches can be successfully generated from human umbilical cord derived myofibroblasts and EPCs. This new cell source may enable the tissue engineering of versatile, living, autologous replacement materials for congenital cardiac interventions.